This regulatory stance underscores the need for caution , emphasizing the importance of consulting healthcare professionals and participating in structured clinical trials to ensure safety, efficacy, and compliance with local laws
In the landmark LEADER trial , liraglutide was shown to reduce the risk of major cardiovascular events including heart attack, stroke, and cardiovascular death in people with type 2 diabetes at high cardiovascular risk
The study, conducted by researchers from the Department of Endocrinology and Diabetes at Max Super Speciality Hospital in New Delhi and the Department of Public Health at Adama Hospital Medical College in Ethiopia, found that younger patients and those who have never taken these drugs before are likely to lose weight more quickly
Goldstein, I., & Goldstein, S
[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Dillon JS, Tanizawa Y, Wheeler MB, Leng XH, Ligon BB, Rabin DU, Yoo-Warren H, Permutt MA, Boyd AE 3rd
doi: 10.1093/toxsci/59.1.169